| Ticker | Action | Number of Shares Bought/Sold | Value of Shares Added/Sold | Average Price paid for previous share BUYs |
|---|
| SDZ.SW - | HOLD | 0 @ CHF 60.1726 | CHF 0 | The current share valuation price of SDZ.SW based on adjusted close was CHF 60.1726. The average price that SDZ.SW shares were previous bought at was CHF 44.1701. The current market price is 36.2% higher than average price they were purchased at. The value of the holding in SDZ.SW has increased by CHF 5,235 compared to the previous valuation of however if the holding was sold on 2025-11-27 this would crystalise an overall loss. |
| IPN.PA - Ipsen SA | HOLD | 0 @ EUR 124.4 | EUR 0 | The current share valuation price of IPN.PA based on adjusted close was EUR 124.4. The average price that IPN.PA shares were previous bought at was EUR 103.683. The current market price is 20.0% higher than average price they were purchased at. The value of the holding in IPN.PA has fallen by EUR 9,325 compared to the previous valuation of Ipsen SA |
| LONN.SW - | HOLD | 0 @ CHF 585.66 | CHF 0 | The current share valuation price of LONN.SW based on adjusted close was CHF 585.66. The average price that LONN.SW shares were previous bought at was CHF 606.416. The current market price is -3.4% lower than average price they were purchased at. The value of the holding in LONN.SW has increased by CHF 187,365 compared to the previous valuation of however if the holding was sold on 2025-11-27 this would crystalise an overall loss. |
| MRK.DE - Merck KGaA | HOLD | 0 @ EUR 115.8 | EUR 0 | The current share valuation price of MRK.DE based on adjusted close was EUR 115.8. The average price that MRK.DE shares were previous bought at was EUR 115.858. The current market price is -0.1% lower than average price they were purchased at. The value of the holding in MRK.DE has increased by EUR 2,750 compared to the previous valuation of Merck KGaA however if the holding was sold on 2025-11-27 this would crystalise an overall loss. |
| NOVN.SW - | HOLD | 0 @ CHF 112.077 | CHF 0 | The current share valuation price of NOVN.SW based on adjusted close was CHF 112.077. The average price that NOVN.SW shares were previous bought at was CHF 101.338. The current market price is 10.6% higher than average price they were purchased at. The value of the holding in NOVN.SW has fallen by CHF 568,250 compared to the previous valuation of |
| NOVO-B.CO - Novo Nordisk A/S | HOLD | 0 @ DKK 41.626 | DKK 0 | The current share valuation price of NOVO-B.CO based on adjusted close was DKK 41.626. The average price that NOVO-B.CO shares were previous bought at was DKK 63.2354. The current market price is -34.2% lower than average price they were purchased at. The value of the holding in NOVO-B.CO has fallen by DKK 605,703 compared to the previous valuation of Novo Nordisk A/S |
| NSIS-B.CO - | HOLD | 0 @ DKK 53.2476 | DKK 0 | The current share valuation price of NSIS-B.CO based on adjusted close was DKK 53.2476. The average price that NSIS-B.CO shares were previous bought at was DKK 61.0647. The current market price is -12.8% lower than average price they were purchased at. The value of the holding in NSIS-B.CO has fallen by DKK 36,102 compared to the previous valuation of |
| ORNBV.HE - Orion Oyj | HOLD | 0 @ EUR 61.65 | EUR 0 | The current share valuation price of ORNBV.HE based on adjusted close was EUR 61.65. The average price that ORNBV.HE shares were previous bought at was EUR 60.1932. The current market price is 2.4% higher than average price they were purchased at. The value of the holding in ORNBV.HE has increased by EUR 32,299 compared to the previous valuation of Orion Oyj however if the holding was sold on 2025-11-27 this would crystalise an overall loss. |
| PHIA.AS - Koninklijke Philips NV | HOLD | 0 @ EUR 24.23 | EUR 0 | The current share valuation price of PHIA.AS based on adjusted close was EUR 24.23. The average price that PHIA.AS shares were previous bought at was EUR 21.0294. The current market price is 15.2% higher than average price they were purchased at. The value of the holding in PHIA.AS has fallen by EUR 9,966 compared to the previous valuation of Koninklijke Philips NV |
| QIA.DE - QIAGEN NV | HOLD | 0 @ EUR 41.445 | EUR 0 | The current share valuation price of QIA.DE based on adjusted close was EUR 41.445. The average price that QIA.DE shares were previous bought at was EUR 42.5094. The current market price is -2.5% lower than average price they were purchased at. The value of the holding in QIA.DE has fallen by EUR 30,548 compared to the previous valuation of QIAGEN NV |
| REC.MI - Recordati Industria Chimica e Farmaceutica SpA | HOLD | 0 @ EUR 50.5 | EUR 0 | The current share valuation price of REC.MI based on adjusted close was EUR 50.5. The average price that REC.MI shares were previous bought at was EUR 53.4467. The current market price is -5.5% lower than average price they were purchased at. The value of the holding in REC.MI has fallen by EUR 2,350 compared to the previous valuation of Recordati Industria Chimica e Farmaceutica SpA |
| ROG.SW - | HOLD | 0 @ CHF 331.281 | CHF 0 | The current share valuation price of ROG.SW based on adjusted close was CHF 331.281. The average price that ROG.SW shares were previous bought at was CHF 281.464. The current market price is 17.7% higher than average price they were purchased at. The value of the holding in ROG.SW has fallen by CHF 1,140,895 compared to the previous valuation of |
| SAN.PA - Sanofi SA | HOLD | 0 @ EUR 85.89 | EUR 0 | The current share valuation price of SAN.PA based on adjusted close was EUR 85.89. The average price that SAN.PA shares were previous bought at was EUR 88.9526. The current market price is -3.4% lower than average price they were purchased at. The value of the holding in SAN.PA has fallen by EUR 164,624 compared to the previous valuation of Sanofi SA |
| HLN.L - Haleon PLC | HOLD | 0 @ GBP 4.2283 | GBP 0 | The current share valuation price of HLN.L based on adjusted close was GBP 4.2283. The average price that HLN.L shares were previous bought at was GBP 4.56586. The current market price is -7.4% lower than average price they were purchased at. The value of the holding in HLN.L has fallen by GBP 13,706 compared to the previous valuation of Haleon PLC |
| SECT-B.ST - | HOLD | 0 @ SEK 26.5101 | SEK 0 | The current share valuation price of SECT-B.ST based on adjusted close was SEK 26.5101. The average price that SECT-B.ST shares were previous bought at was SEK 29.0373. The current market price is -8.7% lower than average price they were purchased at. The value of the holding in SECT-B.ST has increased by SEK 21,710 compared to the previous valuation of however if the holding was sold on 2025-11-27 this would crystalise an overall loss. |
| SFZN.SW - | HOLD | 0 @ CHF 77.3312 | CHF 0 | The current share valuation price of SFZN.SW based on adjusted close was CHF 77.3312. The average price that SFZN.SW shares were previous bought at was CHF 105.102. The current market price is -26.4% lower than average price they were purchased at. The value of the holding in SFZN.SW has increased by CHF 7,336 compared to the previous valuation of however if the holding was sold on 2025-11-27 this would crystalise an overall loss. |
| SHL.DE - Siemens Healthineers AG | HOLD | 0 @ EUR 42.74 | EUR 0 | The current share valuation price of SHL.DE based on adjusted close was EUR 42.74. The average price that SHL.DE shares were previous bought at was EUR 47.9251. The current market price is -10.8% lower than average price they were purchased at. The value of the holding in SHL.DE has increased by EUR 52,699 compared to the previous valuation of Siemens Healthineers AG however if the holding was sold on 2025-11-27 this would crystalise an overall loss. |
| SN.L - Smith & Nephew PLC | HOLD | 0 @ GBP 14.3876 | GBP 0 | The current share valuation price of SN.L based on adjusted close was GBP 14.3876. The average price that SN.L shares were previous bought at was GBP 12.7572. The current market price is 12.8% higher than average price they were purchased at. The value of the holding in SN.L has fallen by GBP 10,008 compared to the previous valuation of Smith & Nephew PLC |
| SOBI.ST - | HOLD | 0 @ SEK 31.259 | SEK 0 | The current share valuation price of SOBI.ST based on adjusted close was SEK 31.259. The average price that SOBI.ST shares were previous bought at was SEK 26.4967. The current market price is 18.0% higher than average price they were purchased at. The value of the holding in SOBI.ST has increased by SEK 28,587 compared to the previous valuation of however if the holding was sold on 2025-11-27 this would crystalise an overall loss. |
| SOON.SW - | HOLD | 0 @ CHF 215.499 | CHF 0 | The current share valuation price of SOON.SW based on adjusted close was CHF 215.499. The average price that SOON.SW shares were previous bought at was CHF 271.632. The current market price is -20.7% lower than average price they were purchased at. The value of the holding in SOON.SW has increased by CHF 46,517 compared to the previous valuation of however if the holding was sold on 2025-11-27 this would crystalise an overall loss. |
| SRT3.DE - Sartorius AG | HOLD | 0 @ EUR 245.4 | EUR 0 | The current share valuation price of SRT3.DE based on adjusted close was EUR 245.4. The average price that SRT3.DE shares were previous bought at was EUR 215.217. The current market price is 14.0% higher than average price they were purchased at. The value of the holding in SRT3.DE has increased by EUR 37,292 compared to the previous valuation of Sartorius AG however if the holding was sold on 2025-11-27 this would crystalise an overall loss. |
| STMN.SW - | HOLD | 0 @ CHF 100.145 | CHF 0 | The current share valuation price of STMN.SW based on adjusted close was CHF 100.145. The average price that STMN.SW shares were previous bought at was CHF 113.693. The current market price is -11.9% lower than average price they were purchased at. The value of the holding in STMN.SW has fallen by CHF 66,291 compared to the previous valuation of |
| TECN.SW - | HOLD | 0 @ CHF 148.879 | CHF 0 | The current share valuation price of TECN.SW based on adjusted close was CHF 148.879. The average price that TECN.SW shares were previous bought at was CHF 178.532. The current market price is -16.6% lower than average price they were purchased at. The value of the holding in TECN.SW has increased by CHF 672 compared to the previous valuation of however if the holding was sold on 2025-11-27 this would crystalise an overall loss. |
| TUB.BR - Financiere de Tubize SA | HOLD | 0 @ EUR 209 | EUR 0 | The current share valuation price of TUB.BR based on adjusted close was EUR 209. The average price that TUB.BR shares were previous bought at was EUR 128.453. The current market price is 62.7% higher than average price they were purchased at. The value of the holding in TUB.BR has increased by EUR 4,514 compared to the previous valuation of Financiere de Tubize SA however if the holding was sold on 2025-11-27 this would crystalise an overall loss. |
| UCB.BR - UCB SA | HOLD | 0 @ EUR 238.5 | EUR 0 | The current share valuation price of UCB.BR based on adjusted close was EUR 238.5. The average price that UCB.BR shares were previous bought at was EUR 162.822. The current market price is 46.5% higher than average price they were purchased at. The value of the holding in UCB.BR has increased by EUR 36,890 compared to the previous valuation of UCB SA however if the holding was sold on 2025-11-27 this would crystalise an overall loss. |
| ZEAL.CO - | HOLD | 0 @ DKK 70.3719 | DKK 0 | The current share valuation price of ZEAL.CO based on adjusted close was DKK 70.3719. The average price that ZEAL.CO shares were previous bought at was DKK 58.9926. The current market price is 19.3% higher than average price they were purchased at. The value of the holding in ZEAL.CO has fallen by DKK 40,191 compared to the previous valuation of |
| DEMANT.CO - | HOLD | 0 @ DKK 29.3216 | DKK 0 | The current share valuation price of DEMANT.CO based on adjusted close was DKK 29.3216. The average price that DEMANT.CO shares were previous bought at was DKK 35.6031. The current market price is -17.6% lower than average price they were purchased at. The value of the holding in DEMANT.CO has increased by DKK 1,993 compared to the previous valuation of however if the holding was sold on 2025-11-27 this would crystalise an overall loss. |
| ALC.SW - | HOLD | 0 @ CHF 68.4841 | CHF 0 | The current share valuation price of ALC.SW based on adjusted close was CHF 68.4841. The average price that ALC.SW shares were previous bought at was CHF 77.6685. The current market price is -11.8% lower than average price they were purchased at. The value of the holding in ALC.SW has fallen by CHF 2,973 compared to the previous valuation of |
| ALK-B.CO - | HOLD | 0 @ DKK 31.0622 | DKK 0 | The current share valuation price of ALK-B.CO based on adjusted close was DKK 31.0622. The average price that ALK-B.CO shares were previous bought at was DKK 23.6007. The current market price is 31.6% higher than average price they were purchased at. The value of the holding in ALK-B.CO has increased by DKK 1,447 compared to the previous valuation of however if the holding was sold on 2025-11-27 this would crystalise an overall loss. |
| AMBU-B.CO - | HOLD | 0 @ DKK 11.7822 | DKK 0 | The current share valuation price of AMBU-B.CO based on adjusted close was DKK 11.7822. The average price that AMBU-B.CO shares were previous bought at was DKK 13.8673. The current market price is -15.0% lower than average price they were purchased at. The value of the holding in AMBU-B.CO has increased by DKK 480 compared to the previous valuation of however if the holding was sold on 2025-11-27 this would crystalise an overall loss. |
| AMP.MI - Amplifon SpA | HOLD | 0 @ EUR 13.335 | EUR 0 | The current share valuation price of AMP.MI based on adjusted close was EUR 13.335. The average price that AMP.MI shares were previous bought at was EUR 20.2713. The current market price is -34.2% lower than average price they were purchased at. The value of the holding in AMP.MI has increased by EUR 9,709 compared to the previous valuation of Amplifon SpA however if the holding was sold on 2025-11-27 this would crystalise an overall loss. |
| ARGX.BR - Argenx SE | HOLD | 0 @ EUR 790.8 | EUR 0 | The current share valuation price of ARGX.BR based on adjusted close was EUR 790.8. The average price that ARGX.BR shares were previous bought at was EUR 508.161. The current market price is 55.6% higher than average price they were purchased at. The value of the holding in ARGX.BR has fallen by EUR 171,726 compared to the previous valuation of Argenx SE |
| AZN.L - AstraZeneca PLC | HOLD | 0 @ GBP 160.127 | GBP 0 | The current share valuation price of AZN.L based on adjusted close was GBP 160.127. The average price that AZN.L shares were previous bought at was GBP 125.063. The current market price is 28.0% higher than average price they were purchased at. The value of the holding in AZN.L has fallen by GBP 884,967 compared to the previous valuation of AstraZeneca PLC |
| BAVA.CO - | HOLD | 0 @ DKK 24.8297 | DKK 0 | The current share valuation price of BAVA.CO based on adjusted close was DKK 24.8297. The average price that BAVA.CO shares were previous bought at was DKK 22.8997. The current market price is 8.4% higher than average price they were purchased at. The value of the holding in BAVA.CO has fallen by DKK 10,601 compared to the previous valuation of |
| BAYN.DE - Bayer AG | HOLD | 0 @ EUR 30.62 | EUR 0 | The current share valuation price of BAYN.DE based on adjusted close was EUR 30.62. The average price that BAYN.DE shares were previous bought at was EUR 25.4056. The current market price is 20.5% higher than average price they were purchased at. The value of the holding in BAYN.DE has increased by EUR 108,591 compared to the previous valuation of Bayer AG however if the holding was sold on 2025-11-27 this would crystalise an overall loss. |
| BIM.PA - BioMerieux | HOLD | 0 @ EUR 109.3 | EUR 0 | The current share valuation price of BIM.PA based on adjusted close was EUR 109.3. The average price that BIM.PA shares were previous bought at was EUR 119. The current market price is -8.2% lower than average price they were purchased at. The value of the holding in BIM.PA has fallen by EUR 14,391 compared to the previous valuation of BioMerieux |
| CAMX.ST - | HOLD | 0 @ SEK 56.1315 | SEK 0 | |
| COLO-B.CO - | HOLD | 0 @ DKK 78.2178 | DKK 0 | The current share valuation price of COLO-B.CO based on adjusted close was DKK 78.2178. The average price that COLO-B.CO shares were previous bought at was DKK 86.1309. The current market price is -9.2% lower than average price they were purchased at. The value of the holding in COLO-B.CO has increased by DKK 10,351 compared to the previous valuation of however if the holding was sold on 2025-11-27 this would crystalise an overall loss. |
| CTEC.L - ConvaTec Group PLC | HOLD | 0 @ GBP 2.68783 | GBP 0 | The current share valuation price of CTEC.L based on adjusted close was GBP 2.68783. The average price that CTEC.L shares were previous bought at was GBP 3.26342. The current market price is -17.6% lower than average price they were purchased at. The value of the holding in CTEC.L has increased by GBP 874 compared to the previous valuation of ConvaTec Group PLC however if the holding was sold on 2025-11-27 this would crystalise an overall loss. |
| ABVX.PA - Abivax SA | HOLD | 0 @ EUR 111.8 | EUR 0 | |
| DIA.MI - DiaSorin SpA | HOLD | 0 @ EUR 61.42 | EUR 0 | The current share valuation price of DIA.MI based on adjusted close was EUR 61.42. The average price that DIA.MI shares were previous bought at was EUR 95.1491. The current market price is -35.4% lower than average price they were purchased at. The value of the holding in DIA.MI has increased by EUR 6,844 compared to the previous valuation of DiaSorin SpA however if the holding was sold on 2025-11-27 this would crystalise an overall loss. |
| DIM.PA - Sartorius Stedim Biotech | HOLD | 0 @ EUR 203 | EUR 0 | The current share valuation price of DIM.PA based on adjusted close was EUR 203. The average price that DIM.PA shares were previous bought at was EUR 198.449. The current market price is 2.3% higher than average price they were purchased at. The value of the holding in DIM.PA has increased by EUR 24,650 compared to the previous valuation of Sartorius Stedim Biotech however if the holding was sold on 2025-11-27 this would crystalise an overall loss. |
| EL.PA - EssilorLuxottica SA | HOLD | 0 @ EUR 313.1 | EUR 0 | The current share valuation price of EL.PA based on adjusted close was EUR 313.1. The average price that EL.PA shares were previous bought at was EUR 248.629. The current market price is 25.9% higher than average price they were purchased at. EUR 0 compared to the previous valuation of EssilorLuxottica SA however if the holding was sold on 2025-11-27 this would crystalise an overall loss. |
| ERF.PA - Eurofins Scientific SE | HOLD | 0 @ EUR 59.24 | EUR 0 | The current share valuation price of ERF.PA based on adjusted close was EUR 59.24. The average price that ERF.PA shares were previous bought at was EUR 57.9209. The current market price is 2.3% higher than average price they were purchased at. The value of the holding in ERF.PA has increased by EUR 9,064 compared to the previous valuation of Eurofins Scientific SE however if the holding was sold on 2025-11-27 this would crystalise an overall loss. |
| FME.DE - Fresenius Medical Care AG | HOLD | 0 @ EUR 41.14 | EUR 0 | The current share valuation price of FME.DE based on adjusted close was EUR 41.14. The average price that FME.DE shares were previous bought at was EUR 47.8642. The current market price is -14.0% lower than average price they were purchased at. The value of the holding in FME.DE has fallen by EUR 7,141 compared to the previous valuation of Fresenius Medical Care AG |
| FRE.DE - Fresenius SE & Co KGaA | HOLD | 0 @ EUR 47.36 | EUR 0 | The current share valuation price of FRE.DE based on adjusted close was EUR 47.36. The average price that FRE.DE shares were previous bought at was EUR 42.5137. The current market price is 11.4% higher than average price they were purchased at. The value of the holding in FRE.DE has fallen by EUR 5,254 compared to the previous valuation of Fresenius SE & Co KGaA |
| GALD.SW - | HOLD | 0 @ CHF 170.835 | CHF 0 | The current share valuation price of GALD.SW based on adjusted close was CHF 170.835. The average price that GALD.SW shares were previous bought at was CHF 119.169. The current market price is 43.4% higher than average price they were purchased at. The value of the holding in GALD.SW has increased by CHF 56,573 compared to the previous valuation of however if the holding was sold on 2025-11-27 this would crystalise an overall loss. |
| GETI-B.ST - | HOLD | 0 @ SEK 19.6051 | SEK 0 | The current share valuation price of GETI-B.ST based on adjusted close was SEK 19.6051. The average price that GETI-B.ST shares were previous bought at was SEK 17.2685. The current market price is 13.5% higher than average price they were purchased at. The value of the holding in GETI-B.ST has increased by SEK 19,136 compared to the previous valuation of however if the holding was sold on 2025-11-27 this would crystalise an overall loss. |
| GMAB.CO - | HOLD | 0 @ DKK 271.928 | DKK 0 | The current share valuation price of GMAB.CO based on adjusted close was DKK 271.928. The average price that GMAB.CO shares were previous bought at was DKK 186.369. The current market price is 45.9% higher than average price they were purchased at. The value of the holding in GMAB.CO has fallen by DKK 77,079 compared to the previous valuation of |
| GRF.MC - Grifols SA | HOLD | 0 @ EUR 10.59 | EUR 0 | The current share valuation price of GRF.MC based on adjusted close was EUR 10.59. The average price that GRF.MC shares were previous bought at was EUR 10.3964. The current market price is 1.9% higher than average price they were purchased at. The value of the holding in GRF.MC has increased by EUR 13,779 compared to the previous valuation of Grifols SA however if the holding was sold on 2025-11-27 this would crystalise an overall loss. |
| GSK.L - GlaxoSmithKline PLC | HOLD | 0 @ GBP 20.593 | GBP 0 | The current share valuation price of GSK.L based on adjusted close was GBP 20.593. The average price that GSK.L shares were previous bought at was GBP 16.9988. The current market price is 21.1% higher than average price they were purchased at. The value of the holding in GSK.L has fallen by GBP 190,399 compared to the previous valuation of GlaxoSmithKline PLC |
| HIK.L - | HOLD | 0 @ GBP 17.9417 | GBP 0 | The current share valuation price of HIK.L based on adjusted close was GBP 17.9417. The average price that HIK.L shares were previous bought at was GBP 23.9671. The current market price is -25.1% lower than average price they were purchased at. The value of the holding in HIK.L has increased by GBP 9,482 compared to the previous valuation of however if the holding was sold on 2025-11-27 this would crystalise an overall loss. |